Sterile normal saline (0.9% sodium chloride solution)
Sponsors
Adarx Pharmaceuticals Inc.
Conditions
Hereditary Angioedema
Phase 3
STOP-HAE: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of siRNA Targeting of Prekallikrein With ADX-324 in Participants With Hereditary Angioedema
Not yet recruitingCTIS2025-521352-38-00
Target: 36Updated: 2025-12-30
A Phase 3 Extension Study of siRNA Targeting of Prekallikrein With ADX-324 in Participants With Hereditary Angioedema
Not yet recruitingCTIS2025-521353-16-00
Target: 23Updated: 2026-06-24